Improvements should be made cautiously along with the frequency of blood glucose monitoring should be amplified. Changes in concomitant oral antidiabetic therapy can be desired. BRIEF SAFETY Assertion: Failure to make use of the Dexcom Constant Glucose Monitoring System and its parts based on the Guidelines to be used https://freds455udm5.wikinarration.com/user